Effect of ERCP utilization and biliary complications on post-liver-transplantation mortality and graft survival.
BACKGROUND
Biliary complications after liver transplant are a frequent source of morbidity. However, little recent mortality data exists related to endoscopic management of these complications.


OBJECTIVE
To determine the effect of endoscopic retrograde cholangiopancreatography (ERCP) utilization and biliary complications on patient and graft survival after liver transplantation.


METHODS
This study was a retrospective cohort study at the University of North Carolina Hospitals from 2004 to 2007. One hundred thirty-two consecutive liver transplant patients were included. Recipient, donor, and clinical data were extracted from electronic resources. The main outcome measurements were all-cause mortality and graft failure.


RESULTS
Of 132 transplants, 59 (45%) required ERCP post transplant, and 49 (37%) were found to have a biliary complication by ERCP. The 1-year patient survival for those treated by ERCP with a biliary complication was 90% compared with 81% in those without a biliary complication [P = 0.018; unadjusted hazard ratio (HR) = 0.32; 95% confidence interval (CI) 0.11-0.93]. The 1-year graft survival in those with and without a biliary complication was 94% and 73%, respectively (P < 0.001; unadjusted HR 0.19; 95% CI 0.07-0.56). This effect on patient and graft survival persisted after multivariate analysis. Similar results were seen for ERCP utilization alone, and when early deaths within the first 30 days were excluded.


CONCLUSIONS
Patients who underwent ERCP for a biliary complication post liver transplantation had better overall and graft survival than patients who did not have an ERCP. Biliary complications and ERCP utilization are common after liver transplant, but they do not confer excess mortality.
Barritt
A Sidney
AS
Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Campus Box 7080, Chapel Hill, NC 27599-7080, USA. abarritt@unch.unc.edu
Miller
C Brock
CB
Hayashi
Paul H
PH
Dellon
Evan S
ES
D000328:Adult; D001660:Biliary Tract Diseases / Q000209:etiology / Q000601:surgery*; D002760:Cholangiopancreatography, Endoscopic Retrograde; D005260:Female; D006085:Graft Survival; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011183:Postoperative Complications / Q000401:mortality / Q000601:surgery; D012189:Retrospective Studies; D015983:Selection Bias; D016019:Survival Analysis
Int Surg. 2006 Sep-Oct;91(5):301-5
17061678
Hepatology. 1991 Nov;14(5):818-23
1937387
Gastrointest Endosc. 2007 Jul;66(1):44-51
17591473
Dig Dis Sci. 2009 Aug;54(8):1798-803
18989776
Ann Surg. 1994 Jan;219(1):40-5
8297175
Liver Int. 2003 Jun;23(3):156-62
12955878
Gastrointest Endosc. 1998 Feb;47(2):128-35
9512276
J Am Coll Surg. 1994 Aug;179(2):177-81
8044387
Gastrointest Endosc. 2009 Jun;69(7):1236-43
19249040
Dig Dis. 1999;17(3):133-44
10697662
Am J Surg. 1992 May;163(5):519-24
1575311
Transplantation. 1987 Jan;43(1):47-51
3541321
Gastrointest Endosc. 2000 Jul;52(1):55-63
10882963
Transplant Proc. 2009 May;41(4):1319-21
19460551
Endoscopy. 2003 Feb;35(2):156-63
12561009
Liver Transpl. 2000 Mar;6(2):201-6
10719021
Surgery. 1989 Oct;106(4):675-83; discussion 683-4
2799642
S Afr J Surg. 1997 May;35(2):77-81
9267176
Scand J Gastroenterol Suppl. 2006;(243):89-101
16782628
Transplantation. 1993 May;55(5):1074-7
8497884